PMN compared with EQ: revenue, margins and what each company keeps, and the suppliers and customers both name

PMNProMIS Neurosciences Inc.

Mkt capRevenueRevenue

EQEquillium, Inc.

Mkt capRevenueRevenue

Compare

PMNProMIS Neurosciences Inc.

EQEquillium, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

PMN: latest quarter not drawable. EQ: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only PMN 0

None

Shared 0

No disclosed counterparties: PMN.

Only EQ 2

—Bioconunlistedsupplier

—Ono Pharmaceuticalunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

PMN, solidEQ, dashed

PMNProMIS Neurosciences Inc.

3.46▼−68.74%· post 3.77

Mkt cap$29.7MRevenue—Revenue—

EQEquillium, Inc.

1.38▼−2.90%· post 1.38

ClosedOct 30 '26

Mkt cap$86.9MRevenue$4MQ4 FY24Revenue$41MFY24

Compare

ClosedOct 30 '26

PMNProMIS Neurosciences Inc.

EQEquillium, Inc.

3.46▼−68.74%post 3.77

Price

1.38▼−2.90%post 1.38

$29.7M

Mkt cap

$86.9M

—

Revenue

$4MQ4 FY24

—

Revenue

$41MFY24

PMN3.46▼−68.74%vsEQ1.38▼−2.90%ClosedOct 30 '26